跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tafnext - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tafnext
Approved
STANDARD
Tafnext
Hetero Labs Limited (Unit-V, Block –VB)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d360832bf384b25e
Company
Hetero Labs Limited (Unit-V, Block –VB)
Type
Standard
Approval Details
Approval Id
d360832bf384b25e
Drug Approval Philippines Name
Tafnext
Product Name
Tafnext
Registration Number
DR-XY48254
Brand Name
Tafnext
Generic Name
Tenofovir alafenamide (as hemifumarate)
Dosage Form
Film Coated Tablet
Dosage Strength
25 mg
Manufacturer
Hetero Labs Limited (Unit-V, Block –VB)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
27 October 2022
Expiry Date
03 August 2027
Pharmacologic Category
Antiviral (Nucleoside/Nucleotide Reverse Transcriptase
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d360832bf384b25e
Type
Standard
Back to Philippines FDA Approvals